Work

Long-term administration of quarterly IV ibandronate is effective and well tolerated in postmenopausal osteoporosis: 5-year data from the DIVA study long-term extension

Year: 2011

Type: article

Source: Osteoporosis International

DOI: 10.1007/s00198-011-1793-9

Authors: G. Bianchi, E. Czerwinski, A. Kenwright, A. Burdeska, R. R. Recker, D. Felsenberg

Institutions: Roche (United Kingdom), F. Hoffmann-La Roche AG, Creighton University, Humboldt-Universität zu Berlin, Charité – Universitätsmedizin Berlin

Language: English

Topic: Bone health and osteoporosis research

Subfield: Orthopedics and Sports Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2016667123

FWCI: 4.758

Cites: 40

Cited by: 54

Related to: 10